|
African Journal of Biomedical Research
Ibadan Biomedical Communications Group
ISSN: 1119-5096
Vol. 4, Num. 3, 2001, pp. 111-113
|
African Journal of Biomedical Research, Vol. 4, No. 3, Sept, 2001, pp. 111-113
Original article
EFFECT OF MAGNESIUM
SUPPLEMENTATION ON PLASMA GLUCOSE IN PATIENTS WITH DIABETES MELLITUS
MELUDU S. C1* AND ADENIYI
F. A. A2
1Diabetology
Unit, Department Of Medicine, University Hospital, University
Of Liege, Belgium
2Department of Chemical Pathology, College of Medicine, University
of Ibadan. Ibadan, Nigeria
*Address for correspondence: DrS.C. Meludu is presently at the Department
of Human Biochemistry, College of Health Sciences, NnamdiAzikiweUniversity,
P.M.B. 5001, Nnewi, Anambra State, Nigeria
Code Number: md01061
Magnesium
depletion and/or deficiency are known feature of diabetes mellitus, and could
lead to increased insulin resistance and diabetic complications. This study
therefore looked at the potential benefit of magnesium administration on the
management of diabetic mellitus. Twelve apparently healthy and 6 non-insulin
dependent diabetic (NIDDM) subjects received 15mmol (360 mg) elemental
magnesium as NUG2 (Meram Laboratories, France) in 500 ml of 0.9% saline intravenously over four hours.
Blood samples were collected at baseline and at hourly intervals. The diabetic
subjects had lower ionized (0.41±0.03 vs 0.48±0.01 mmoIAL; P< 0.05) and
total (0.73±0.04 vs 0.88±0.02 mmol/L; P< 0.05) plasma magnesium
concentrations than the non-diabetic subjects, reflecting a depletion of body
magnesium. The administration of magnesium led to a significant increase in
ionized and total plasma magnesium in both non-diabetic and diabetic subjects.
Similarly, plasma glucose and insulin were significantly decreased, and
homeostasis model assessment showed an increase in insulin sensitivity in
diabetic subjects. In established cases of magnesium depletion and/or
deficiency in diabetes mellitus, magnesium supplementation could be of great
benefit in diabetic management.
Key words: Magnesium depletion-Magnesium administration-Diabetes
mellitus-Insulin resistance.
INTRODUCTION,
Magnesium is an essential element in the mechanism of
glucose transport across the cell membrane (Aikawa, 198 1; Goldman and Fisher,
1984), and various enzymes, important in carbohydrate oxidation require
magnesium as a cofactor (Lehninger, 1950). Tissue magnesium
deficiency/depletion and clinical manifestations of the deficiency can be
present despite normal or borderline serum/plasma concentration (Zaloga, 1989).
In diabetes mellitus, magnesium depletion is a
common occurrence (Speich et al, 1992; Schnack et al, 1992;
Resnick et al, 1993), and it has been reported to exacerbate/contribute
to reduced insulin sensitivity (Durlach and Rassiguier, 1983; Legrand et al,
1987) in non-insulin dependent diabetes mellitus. Magnesium administration was
shown to increase plasma and erythrocyte magnesium levels and improve insulin
response and action (Sjogren et al, 1988; Paolisso et al, 1992),
due to an increased affinity of insulin to its receptors (Ishii, 1989).
Therefore, magnesium administration/supplementation could prove to be
beneficial in the management of diabetics. This study essentially focused on
the effects of magnesium administration on glucose metabolism and insulin
sensitivity.
MATERIALS AND METHODS
Twelve apparently healthy (9 males and 3 females) non-obese,
and 6 NIDDM (3 males and 3 females) participated in the study. The
non-diabetic subjects were aged, 28.8±1.7years, with BMT of 23.7± 0.9kg/m.
Diabetic subjects were aged 47.7± 2.7 years with BMT of 24.6 ± 1.6 kg/m and
glycosylated hemoglobin of 7.0 ± 0.4%. The study was carried out in diabetology
unit, department of Medicine, UniversityHospital, University of Liege, Belgium.
15 mmol (360 mg) of elemental magnesium in 500 ml of
0.9% saline was given as an intravenous infusion over 4 hrs at a rate of 125
ml/hr with an IMED pump (IMED Co., San Diego, Calif.). Blood samples were collected
under
vacuum with an indwelling catheter at 0, 60, 120,180 and 240 minutes. Ionized
and total plasma magnesium, plasma glucose and insulin were determined. On the
day of the study, diabetic subjects were not allowed to take drugs.
The ionized plasma magnesium was determined by ion
selective electrode (NOVA 8, NOVA Biomedicals, USA), total plasma magnesium determined
by atomic absorption spectrometry (Perkin-Elmer Atomic Absorption Spectrometer
403/242). Plasma glucose concentration was determined with the use of AU 5000
Olympus Auto analyzer system, whereas plasma insulin concentration was
determined by radio-immunoassay method. Percentage insulin sensitivity was
calculated with Homeostasis Model Assessment (HOMA) computer program (Diabetes
Research Laboratory, Radcliffe Infirmary, UK).
The results are presented as mean ± SEM.
RESULTS.
Diabetic subjects were older than non-diabetics (47.7±2.7 vs
28.8±1.7 yrs; P< 0.05), but their body mass indexes were similar (24.6±1.1.6
vs 23.7+0.9 kg/m2). The pre-infused values of ionized and total
plasma magnesium were lower in diabetics than in non-diabetics (Fig 1). On the
other hand, the fasting plasma glucose and insulin concentrations were higher
in diabetics compared with non-diabetics (Fig 1). Ionized and total plasma
magnesium concentrations increased in both diabetic and non-diabetic subjects
throughout the period of magnesium infusion (Fig 1). Plasma glucose
concentration in diabetics decreased significantly all through the period of magnesium
administration, whereas the decrease was only significant in non-diabetics
after 240 minutes (Fig 1). Plasma insulin also decreased significantly in
diabetics from 120 minutes through 240 minutes and in non-diabetics throughout
the period of magnesium infusion. Whereas plasma glucose concentration was
higher in diabetics than in nondiabetics at all sampling time, plasma insulin
was similar in the two group of subjects, except at 60 minutes when if was
higher in diabetics.
DISCUSSION
Diabetes mellitus or more specifically hyperglycemia with
glycosuria appears to induce magnesium depletion both directly via osmotic
diuresis and indirectly by its effects on vitamins, ions and protein (Sjogren et
al, 1986; Campbell, 1987). In humans, sugar loading had been shown to cause
magnesuresis and could result in intracellular magnesium depletion.
In this study, diabetics had a significant decrease
in both ionized and total plasma magnesium concentrations compared with
non-diabetics as previously reported (Resnick et al, 1993; Meludu et
al, 1994). The depletion in ionized magnesium concentration, which is the
physiologically active form of magnesium and readily exchangeable (Reinhart,
1990; Reinhart, 1991) does suggest whole body magnesium depletion (intracellular
and extracellular).
Ionized and total plasma magnesium concentrations
increased significantly following intravenous administration of magnesium in
both diabetic and non-diabetic subjects. Interestingly, ionized plasma
magnesium concentration only differed significantly after the first 60 minutes
in the two groups of subjects, because of the initial difference in the
pre-infused magnesium concentration. In fact, ionized magnesium easily
equilibrates with other compartments and it reflects the immediate changes that
occur following magnesium administration.
Plasma glucose concentration in both diabetic and
non-diabetic subjects was decreased following magnesium administration. In
normal subjects, glucose homeostasis in fasting state is maintained constant
by
control of hepatic glucose output, with the rate of entry of glucose into
circulation approximating the rate of removal (Dinnen et al, 1992). The
decrease in plasma glucose could therefore be attributed to the direct effect
of magnesium on glucose disposal, since magnesium is important for the action
of the rate limiting enzymes of glycolysis (Altura, 1982).
Ionized and total plasma magnesium, plasma glucose and
insulir# concentrations during intravenous magnesium administration to
diabetics (open squares) and normal subjects (closed circles). + P< 0.05
between diabetic and normal subjects, P< 0.05 within diabetics, # P< 0.05
within normal subjects,
Plasma insulin concentration was also decreased
following magnesium administration to diabetic and non-diabetic subjects.
Analysis by Homeostasis Model Assessment (HOMA) computer program showed a
significant increase in percent insulin sensitivity, even though to a lesser
extent in diabetics (data not shown). Interestingly, percent B-cell response
was decreased in non-diabetics, whereas it was not affected in diabetic
subjects. The overall effect of magnesium administration on plasma glucose and
insulin is therefore on the increase in glucose disposal as a result of an
increase in insulin activity (Paolisso et al, 1992). In effect,
hypermagnesemia inhibits insulin secretion (Zofkova et al, 1988), while
it enhances insulin sensitivity through increase in binding affinity of insulin
to its receptors (Yajnlk et al, 1984; Paolisso et al, 1992). In
conclusion, magnesium administration/ supplementation as an additi6iial means
of diabetic patient management will enhance glucose oxidation and restore the
magnesium losses.
ACKNOWLEDGEMENT
Our profound thanks to Prof P. J. Lefebvre and his team at
the Department of Medicine, Un -ivers ity of Leige, Belgium for all their support to M. S. C.
REFERENCES
-
Aikawa, J. K. (1981). Magnesium: Its biological significance. Boca
Raton,Fla,CRC Press Inc.
-
Altura, B. M. (1982). Magnesium and. regulation of contractility of vascular
smooth muscle. Adv. Mcrocirc. 11, 77-113.
-
Campbell, R. K. (1987), Magnesium and diabetes: a clinical concern? Prac.
Diabetol. May/June, 8-9.
-
Dinnen, S., Gen'ch, J. and Rizza. R. (1992). Carbohydrate metabolism in
non-insulin dependent diabetes mellitus. N. Engl. J. Med. 327, 707-713.
-
Durlach, J. and Rassiguier, Y. (1983). Magnesium et glucides 1. Donnes
cliniques et therapeutiques. Magnesium. 2,192-224.
-
Goldman, J. and Fisher, V. (1984). Magnesium is required in addition
to calcium for insulin stimulation of glucose transport. In: The Endocrine
Society; abstract of 65 lb annual meeting, San Antonio, Texas, 1983. Baltimore,
Md; Endocrine Society. 271.
-
Ishii, T. (I 989). Effect of magnesium on the action of insulin during glucose
metabolism. J. OsakaCity
Med. Center. 38, 675-689.
-
Legrand, C., Okitolonda, W., Potter, A. M., Lederer, J. and
Henquin, J. C (1987).
Glucose homeosrtasis in magnesium deficient rats. Metabolism. 36, 160-164.
-
Lehninger, A. S. (I 950). Role of metal ions inenzyme systems.
Physiol. Rev. 30, 393429.
-
Meludu, S. C., Castillo, M. J., Scheen, A. J., and Lefebvre,
P. J. (1994).
Decrease plasma ionized magnesium levels in type I and type 2 diabetic
patients. NUgnesium Res. 7 (supple 1), 23-24.
-
Paolisso, G., Sgambato, S., Gambardella, A., Pizza, G.,
Tesauro, P., Varricchlo, M. and D'Onofrio, F. (1992). Daily magnesium
supplements improve glucose handling in elderly subjects. Am. J. Clin. Nutr.
55, 1161-7.
-
Reinhat R. A. (1990). Magnesium metabolism. Wisconsin Med. J.
Oct, 579-583.
-
Reinhart, R. A. (1991). Clinical correlates of the molecular and cellular
actions of magnesium on the cardiovascular systems. Am. Heart J.121,
1513-1521.
-
Resnick, L. M., Barbagallo, M., Gupta, R. K. and Laragh, J.
H. (1993). Ionic
basis of hypertension in diabetes mellitus: Role of hyperglycemia. Am. J.
Hypertens. 6, 413-417.
-
Schnack, Ch.,
Bauer, I., Pregant, P., Hopmeier, P. and
Schemthaner, G. (1992). Hypomagnesemia in type 2 (non-insulin-dependent) diabetes mellitus isnot corrected by improvement of long-term metabolic control. Diabetologia.
3 5, 77-79.
-
Sjogren, A., Floren, C. H. and Nilssson, A. (1986). Magnesium deficiency in IDDM
related to level of glycosylated hemoglobin. Diabetes. 35, 459-463.
-
Sjogren, A., Floren, C. H. and Nilsson, A. (1988). Oral administration of magnesium
hydroxide to subjects with insulin-dependent diabetes mellitus: effects on
magnesium and potassium levels and on insulin requirement. Magnesium.
7, 117-122.
-
Speich, M., Murat, A., Auget, J. L., Bousquet, B. and Amaud,
P. (1992).
Magnesium, total calcium, phosphorous, copper and zinc in plasma and
erythrocyte of venous cord blood from infants of diabetic mothers, comparison
with a reference group by logistic discriminant analysis. Clin. Chem.
3 8, 2002-2007.
-
Yajnlk, C. S., Smith, R. F., Hockaday, T. D. R. and Ward, N.
1. (1984). Fasting
plasma magnesium concentrations and glucose disposal in diabetes. Br. Med. J.
28 8, 1032-1034.
-
Zaloga, G. P. (1989). Interpretation of the serum magnesium levels. Chest.
95, 257-8.
-
Zofkova, I., Zamrazil, V. and Simeckova, A. (1988). Acute hypennagnesemia retards
glucose assimilation and inhibit insulin secretion during intravenous glucose
tolerance test (IVGTT). Horm. Metab. Res. 20,120-121.
© 2001 - Ibadan Biomedical Communications Group
|